Equities

Medistim ASA

Medistim ASA

Actions
Health CareMedical Equipment and Services
  • Price (NOK)140.00
  • Today's Change-0.50 / -0.36%
  • Shares traded10.70k
  • 1 Year change-22.65%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of NOK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments146144129
Total Receivables, Net8811480
Total Inventory14511497
Prepaid expenses4.674.55--
Other current assets, total7.798.48--
Total current assets392386306
Property, plant & equipment, net575159
Goodwill, net141414
Intangibles, net312216
Long term investments------
Note receivable - long term6.335.794.48
Other long term assets0.000--
Total assets506483403
LIABILITIES
Accounts payable252413
Accrued expenses172622
Notes payable/short-term debt000
Current portion long-term debt/capital leases8.387.097.11
Other current liabilities, total444335
Total current liabilities9410078
Total long term debt9.261017
Total debt181724
Deferred income tax------
Minority interest------
Other liabilities, total4.235.132.51
Total liabilities10811597
SHAREHOLDERS EQUITY
Common stock4.594.594.59
Additional paid-in capital424242
Retained earnings (accumulated deficit)327303246
Treasury stock - common(0.01)(0.02)(0.03)
Unrealized gain (loss)------
Other equity, total251913
Total equity398368306
Total liabilities & shareholders' equity506483403
Total common shares outstanding181818
Treasury shares - common primary issue0.060.090.11
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.